Ads
related to: darzalex daratumumab- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- About DARZALEX®
Learn About a Treatment Method and
How DARZALEX® Works
- Important Safety Info
Learn About Important Safety
Information for DARZALEX®
- Preparing For Treatment
Watch a Video About What to Expect
Before, During, & After Treatment
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- Questions for Your Doctor
Find a List Of Questions for You to
Ask Your Healthcare Provider
- DARZALEX® Side Effects
Search results
Genmab: Growth Is Still a Better Choice
GuruFocus.com via Yahoo Finance· 3 months agoGenmab AS (NASDAQ:GMAB) is one of the largest Danish pharmaceutical companies focused on developing medicines to treat patients with cancer, multiple...
Halozyme's (HALO) Q3 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 2 years agoHalozyme Therapeutics, Inc. HALO reported third-quarter 2022 adjusted earnings of 74 cents per...
Halozyme (HALO) Q1 Earnings Disappoint, Revenues Rise Y/Y
Zacks via Yahoo Finance· 1 year agoHalozyme Therapeutics, Inc. HALO reported first-quarter 2023 adjusted earnings of 47 cents per...
Halozyme Therapeutics Shares Jump On Better Than Expected Annual Guidance
Benzinga via Yahoo Finance· 2 years agoHalozyme Therapeutics Inc (NASDAQ: HALO) reported Q2 revenue of $152.4 million, +12% Y/Y, surpassing...
Halozyme (HALO) Q4 Earnings Match Estimates, Revenues Lag
Zacks via Yahoo Finance· 3 months agoHalozyme Therapeutics, Inc. HALO delivered fourth-quarter 2023 adjusted earnings of 82 cents per...
Pervez Musharraf, Pakistan martial ruler in 9/11 wars, dies
Politico via Yahoo News· 1 year agoISLAMABAD — Gen. Pervez Musharraf, who seized power in a bloodless coup and later led a reluctant...
Bristol Myers (BMY), TSVT Application for Abecma Accepted
Zacks via Yahoo Finance· 1 year agoBristol Myers Squibb BMY and partner 2seventy bio, Inc. TSVT announced that the FDA has accepted the...
Halozyme Therapeutics (HALO) Down 34.4% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Halozyme Therapeutics (HALO). Shares...
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In...
Benzinga via Yahoo Finance· 1 year agoImmix Biopharma Inc's (NASDAQ: IMMX) subsidiary Nexcella Inc announced updated AL Amyloidosis...
Why Is Halozyme Therapeutics (HALO) Up 2.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 6 months agoA month has gone by since the last earnings report for Halozyme Therapeutics (HALO). Shares have...
Ad
related to: darzalex daratumumab